Cornercap Investment Counsel Inc Cullinan Oncology, Inc. Transaction History

Cornercap Investment Counsel Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$15.63 - $29.35 $110,785 - $208,032	-7,088 Reduced 38.15%	11,491 $200,000
Q1 2024 May 10, 2024	SELL	$10.17 - $19.02 $1,413 - $2,643	-139 Reduced 0.74%	18,579 $316,000
Q4 2023 Jan 30, 2024	BUY	$7.89 - $10.23 $1,002 - $1,299	127 Added 0.68%	18,718 $190,000
Q3 2023 Nov 13, 2023	SELL	$9.05 - $11.72 $1,846 - $2,390	-204 Reduced 1.09%	18,591 $168,000
Q2 2023 Aug 11, 2023	BUY	$8.8 - $13.4 $25,132 - $38,270	2,856 Added 17.92%	18,795 $202,000
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $188,398 - $245,779	15,939 New	15,939 $204,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.